Acquisition of pharmaceutical active ingredients’ business


Menarini has signed the acquisition of the Lodichem’s pharmaceutical active ingredients manufacturing facility from Euticals. An investment of 10 million euro is planned for the development and re-launch of the facility, that will complement the Menarini plants of Pisa and Lomagna. Lodichem will produce high-quality active ingredients for strategic products. The project involves the construction of a new building for offices and quality-control laboratories, as well the refurbishing of numerous systems. The acquisition comes two months after the creation of VaxYnethic, a joint venture in the field of biopharmaceutical production signed between Menarini and BiosYnth.



Please enter your comment!
Please enter your name here